Close Menu

NEW YORK (360Dx) – UK diagnostics firm Oncimmune announced today that it has signed on Sabartech as the exclusive distributor of its lung cancer test EarlyCDT-Lung in Portugal.

The test, which was launched in the US in 2012, is designed to measure levels of seven auto-antibodies to tumor-associated antigens. According to Oncimmune, it can detect all forms of lung cancer at any stage.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.